Richard John Rees Purchases 98,000 Shares of Creo Medical Group PLC (LON:CREO) Stock

Creo Medical Group PLC (LON:CREO) insider Richard John Rees bought 98,000 shares of the company’s stock in a transaction on Thursday, October 24th. The stock was purchased at an average cost of GBX 20 ($0.26) per share, with a total value of £19,600 ($25,447.94).

Creo Medical Group Stock Performance

Shares of CREO stock opened at GBX 20 ($0.26) on Friday. Creo Medical Group PLC has a fifty-two week low of GBX 19 ($0.25) and a fifty-two week high of GBX 50 ($0.65). The company has a 50 day moving average price of GBX 25.91 and a 200 day moving average price of GBX 31.02. The stock has a market capitalization of £72.36 million, a P/E ratio of -333.33 and a beta of 0.86. The company has a debt-to-equity ratio of 29.96, a quick ratio of 2.19 and a current ratio of 3.24.

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.